All In MedTech

Device Trial Radar · NCT05875987

Evaluation of the Quantra QStat System in Obstetric Patients

Pilot Study Evaluating the Clinical Performance of the Quantra With the QStat Cartridge at the Point-of-care in Obstetric Patients

Last checked: Nov 20, 2026Latest source record: May 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Jun 1, 2023

Primary completion

Mar 31, 2024

Study completion May 10, 2024

Sponsor

Lead sponsor
HemoSonics LLCNot on our public-company list
Sponsor type
Industry
First posted
May 25, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.

Conditions

  • Blood Loss Massive
  • Post Operative Hemorrhage

Interventions

  • Quantra SystemDevice

    Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of Quantra Clot Time to laboratory aPTT test resultsTime frame: At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth
  2. Comparison of Quantra Fibrinogen Contribution to Clot Stiffness to laboratory coagulation fibrinogen test resultsTime frame: At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth
  3. Comparison of Quantra Clot Time to ROTEM delta INTEM CT test resultsTime frame: At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Duke University Hospital

    Durham, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.